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Abstract
Background Laparoscopic sleeve gastrectomy (LSG) is a pop-
ular treatment for adolescent morbid obesity. Research on LSG
outcomes among adolescents assessed a narrow range of an-
thropometric, nutritional, or cardiometabolic parameters, lead-
ing to an incomplete picture of these changes. We examined a
wide variety of anthropometric, nutritional, and cardiometabol-
ic parameters among adolescents before and after LSG.
Methods We retrospectively reviewed medical charts of all
obese adolescents who underwent LSG at Hamad Medical
Corporation, Qatar, between January 2011 and June 2015
(N = 102). We assessed preoperative levels and postoperative
changes in 4 anthropometric, 15 nutritional, and 10 cardiomet-
abolic parameters.
Results The study sample comprised 79 patients with com-
plete information (36 males, mean age 15.99 ± 1.1 years). At a
mean of 24.2 months post-LSG, we observed (1) significantly
reduced meanweight and bodymass index by 51.82 ± 28.1 kg
and 17 ± 6.24 kg/m2, respectively; (2) the highest prevalence
of post-LSG deficiencies pertained to vitamin D, albumin, and
ferritin (89.3, 38, and 33.3%, respectively); (3) low hemoglo-
bin levels (29.3%) only in females; (4) trace elements were not
deficient; (4) significant reductions in percentage of adoles-
cents with elevated low-density lipoprotein (from 66.1 to
38.9%), alanine aminotransferase (from 45.3 to 10.9%), and
aspartate aminotransferase (from 24.1 to 8.6%) levels; (5)
100% remission of prediabetes cases; and (6) 80% remission
of type 2 diabetes cases.
Conclusions LSG achieved significant weight loss and im-
provement of cardiometabolic risk factors among adolescents.
However, the slight worsening of preexisting nutritional defi-
ciencies warrants careful preoperative surveillance and appro-
priate postoperative nutritional supplementation.
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Introduction
Adolescent obesity, a serious public health challenge, can per-
sist into adulthood and contribute to premature development
of type II diabetes (T2DM), dyslipidemia, increased cardio-
vascular disease, reduced quality of life, and early mortality
[1, 2]. As nonsurgical treatments (e.g., lifestyle modification/s,
medication/s) are modestly effective for extremely obese ad-
olescents [3], bariatric surgery has been increasingly utilized
to achieve weight loss and resolution of comorbidities among
such adolescents.
Laparoscopic sleeve gastrectomy (LSG) is increasingly
employed in adolescents [4], with good safety profile, durable
weight loss, and comorbidity resolution [5]. Although LSG is
primarily a restrictive (rather thanmalabsorptive) procedure, it
carries the risk of some nutritional deficiencies (NDs) related
to postoperative restricted caloric intake, food intolerance,
and/or insufficient supplementation [6]. Moreover, preopera-
tive nutritional deficiencies (due to high consumption of en-
ergy dense and nutritionally poor food), could worsen after
LSG, if not recognized and treated [7, 8]. Nevertheless, LSG
can improve obesity-related cardiometabolic risk factors [9].
The literature on adolescent LSG reveals several gaps in
terms of nutritional deficiencies and cardiometabolic out-
comes. First, most bariatric adolescent studies have focused
on gastric bypass/gastric band rather than on LSG [10].
Additionally, most post-LSG adolescent research evaluated
weight loss and perioperative complications [11, 12],
overlooking the postoperative nutritional changes that are crit-
ical in adolescence. An exception is a post-LSG study of a
narrow range of cardiometabolic and nutritional deficiency
outcomes [9] that did not assess any trace elements, despite
their importance. Moreover, the evidence regarding post-LSG
comorbidity resolution in adolescence is scarce, with many
shortcomings, that include the reporting of: (1) only crude
outcomes (e.g., dyslipidemia, with no details of individual
lipids) [13], or only single lipids (e.g., triglycerides or high-
density lipoproteins) [14, 15]; or, (2) only cardiometabolic
outcomes with no nutritional deficiency parameters [14]. In
addition, despite the rising adolescent obesity rates in the
Eastern Mediterranean Region [16], there exits only two pub-
lished studies on LSG outcomes in adolescents: both exam-
ined cardiometabolic outcomes (no nutritional deficiency as-
sessment) [17, 18], where the latter study had short follow-up
(8 months).
Therefore, the current study bridged these gaps, com-
paring mean preoperative values of 4 anthropometric, 15
nutritional, and 10 cardiometabolic outcomes with post-
operative changes at 2 years. We also assessed the post-
operative evolution of de novo cases of nutritional and
cardiometabolic outcomes. These factors highlight the
importance of the current study and its contribution to
the emerging evidence base.
Materials and Methods
Study Design, Ethics, and Participants
This retrospective study comprised all adolescents [N = 102,
aged 13–17 years, body mass index (BMI) ≥ 40 or ≥ 35 with
comorbidities] who underwent primary or revisional LSG be-
tween January 2011 and June 2015 at the Bariatric and
Metabolic Surgery Centre, Hamad Medical Corporation,
Doha, Qatar. The majority of the sample (97.5% of patients)
had undergone primary LSG procedures, and only two pa-
tients had conversion from laparoscopic gastric band. The
study was approved by Hamad Medical Corporation
(Protocol No. 16308116). Follow-up information was missing
for 23 adolescents; hence, the current analysis included the
data of 79 adolescents.
Procedures and Data Collection
We reviewed patients’ medical charts/electronic records and
retrieved data that included demographics and preoperative
and 2-year postoperative information on
1. Anthropometric outcomes [weight, BMI, excess weight
(EW) reduction, excess weight loss percentage (EWL%)].
2. Nutritional deficiency outcomes [hemoglobin, hemato-
crit, mean corpusacular volume (MCV), iron, ferritin, to-
tal protein, albumin, calcium, magnesium, phosphate,
zinc, copper, vitamin D, vitamin B12, folic acid].
3. Cardiometabolic outcomes [changes in total cholesterol
(TC), low-density lipoprotein (LDL), high-density lipo-
protein (HDL), triglycerides (TGs), alanine aminotrans-
ferase (ALT), aspartate aminotransferase (AST), fasting
blood glucose (FBG), hemoglobin A1c (HbA1c), para-
thyroid hormone (PTH), and uric acid levels].
Standard referential values were adopted for all biochemi-
cal blood assays.
Assessment of Weight Change
We assessed BMI [weight (kg) / height (m2)], EW [current
weight (kg) − ideal body weight (kg)], EWL% [(preoperative
weight − current weight / (preoperative weight − ideal body
weight) × 100] [19] and ideal body weight (kg) [22 × height
(m2)] [20].
Definition of Cardiometabolic Comorbidities
We defined dyslipidemia as TC ≥ 5.17 mmol/L,
LDL ≥ 3.36 mmol/L, HDL ≤ 1 mmol/L, and TG ≥ 1.4 mmol/L;
type 2 diabetes as FBG ≥ 7 mmol/L or HbA1c ≥ 6.5%); and
prediabetes asHbA1c 5.7–6.4%or FBG5.6–6.9mmol/L [21, 22].
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Definition of Cardiometabolic Comorbidity Resolution
We focused only on complete resolution of comorbidities. We
def ined l ip id resolu t ion as TC < 5.17 mmol /L,
LDL < 2.8 mmol/L, HDL > 1.2 mmol/L, and TG < 1 mmol/
L; prediabetes resolution as FBG < 5.5 mmol/L and
HbA1c < 5.7%); and T2DM resolution as FBG < 5.5 mmol/
L and HbA1c < 6% without antidiabetic medication [21, 23].
Surgical Technique
Procedure started with division of gastro-splenic ligament
along the greater curvature 4 cm from the pylorus up to the
left diaphragmatic crus with ultrasonic shears. Stomach was
then mobilized and divided along the lesser curvature from
antrum (4 cm from pylorus) up to the angle of His using
buttressed (SeamGuard) linear 60-mm stapler (Covidien
Tristapler) or Echelon Flex over the calibration tube
(Midsleeve 38 Fr) introduced into the stomach. Specimen
was removed through the umbilical port. Procedure was con-
cluded with methylene blue leak test.
Nutritional Deficiency Management Protocol
Adolescents with vitamin/s and/or mineral deficiencies in the
preoperative assessment received treatment accordingly prior
to surgery. In addition, any ND identified postoperatively was
addressed as indicated. All patients were restricted to a liquid
diet during the first three postoperative weeks with protein
shake supplement provided for each patient to ensure ade-
quate protein intake. Standardized nutritional supplements
were also provided. These included daily multivitamin tablets
containing vitamins A (retinol) C, D3, E K, B1 (thiamine), B2,
B3, B5, B6 (pyridoxine), B8, B12 (cobalamin), and folate and
the minerals chrome, iron, magnesium, selenium, and zinc.
Statistical Analysis
Categorical and continuous values were expressed as frequen-
cies (percentages) and means ± SDs. Descriptive statistics
were used to summarize demographic, clinical, anthropomet-
ric, nutritional, cardiometabolic, and liver function parameters
and other related characteristics. Kolmogorov-Smirnov test
was used to test for normality of the data. Paired t test was
used to compare preoperative and postoperative (2 years post-
LSG)mean changes in anthropometric, nutritional, cardiomet-
abolic, and liver function parameters (quantitative outcome
measures). Statistical analyses were performed using statisti-
cal package SPSS 22.0 (SPSS Inc., Chicago, IL); two-tailed P
values < 0.05 were considered statistically significant.
Results
Changes of Anthropometric Parameters
The sample comprised 36 males (45%), mean age
15.99 ± 1.07 years (range, 13–17 years). At 2-year follow-
up (M = 24.2 ± 12.2 months), significant reductions were
found in weight, BMI, and excess weight (Table 1).
Changes of Nutritional Parameters
Table 2 shows that the only preoperative deficiency pertained
to vitamin D (M = 11.73 ± 6.06 ng/mL), and this deficiency
persisted postoperatively (M = 17.73 ± 9.33 ng/mL). The pre-
operative and postoperative mean values of all remaining nu-
tritional parameters were normal. Compared to preoperative
levels, significant increases in the mean levels of hematocrit
(only for males), MCV, iron, and vitamin D were detected
postoperatively; conversely, significant decreases were found
in mean levels of total protein, copper, and vitamin B12.
Table 3 shows the subset of the sample with preoperative or
postoperative nutritional deficiencies or both. Preoperatively,
vitamin D deficiency was observed across most (96.4%) ado-
lescents, followed by ferritin, albumin, iron, and other defi-
ciencies (range, 4.7–39.4%). Postoperatively, vitamin D defi-
ciency was still observed in 89.3% of adolescents, followed
by albumin, ferritin, hemoglobin, iron, and other deficiencies
(range, 4.6–38%). However, the differences between preoper-
ative and postoperative deficiencies were not statistically
significant.
Evolution of Nutritional Deficiencies (De Novo Cases)
Table 3 depicts postoperative de novo cases with nutritional
deficiencies. The most frequent de novo deficiency was low
albumin (14 patients), followed by hematocrit, hemoglobin,
vitamin B12, vitamin D, and other de novo deficiencies
(range, 1–5 patient/s). De novo deficiencies of minerals and
trace element were either absent (e.g., magnesium, phosphate,
zinc) or rare (e.g., copper, one patient).
Changes of Cardiometabolic Parameters
Table 4 shows elevated levels of preoperative ALT, FBG,
HbA1c, and uric acid. Postoperatively, mean values of all
initially elevated cardiometabolic parameters returned to nor-
mal, except for uric acid, which remained slightly above the
upper normal limit (356 ± 85.52 μmol/L). Additionally, sig-
nificant decreases (i.e., return to normal) were observed for
TC, LDL, HDL, TG, FBG, HbA1c, and liver enzymes’ mean
values. Conversely, no significant decreases were detected in
the mean values of PTH and uric acid.
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Evolution of Cardiometabolic Risk Factors (De Novo
Cases)
Significant postoperative improvements were found in the
percentage of patients with elevated LDL, ALT, and AST.
Similar improvements were seen in patients with T2DM and
prediabetes (Table 5). We also observed a 100% remission
among adolescents with preoperative elevated TG levels and
prediabetes. The postoperative remissions of the remaining
cardiometabolic parameters ranged between 21.1 and 90%.
The numbers of de novo cases were generally low across most
cardiometabolic parameters, with the exception of HDL (four
de novo low HDL cases), LDL (three de novo elevated LDL
cases), and AST (three de novo elevated AST cases).
Discussion
Few studies have examined the nutritional and cardiometabol-
ic outcomes of adolescent bariatric surgery beyond 1 year [9,
24]. To the best of our knowledge, this is the first research in
the Eastern Mediterranean Region assessing a comprehensive
range of LSG outcomes. Two years after LSG, adolescents
generally showed impressive improvements in anthropomet-
ric (weight, BMI, EWL%, Table 1), nutritional (hematocrit,
MCV, iron, vitamin D, Table 2), and cardiometabolic (TC,
LDL, HDL, TG, T, ALT, AST, Table 2) outcomes.
Anthropometric Outcomes
Weobserved significant weight reduction (mean = 51.82 kg) that
exceeded post-LSG weight reductions reported by recent studies
(39 kg in USA and 40 kg in France) [9, 14]. Interestingly, this
higher weight reduction occurred despite the fact that mean BMI
in our study was lower than that reported in previously men-
tioned studies [9], although the literature suggests that, among
Table 2 Preoperative and postoperative mean values of nutritional parameters
Parameter Normal values (unit) Preop Postopa Difference
M ± SD
P
M ± SD M ± SD
Hemoglobin
Male 13.8–16 (mg/dL) 14.10 ± 1.25 14.43 ± 2.01 0.28 ± 1.9 0.40
Female 12.1–16 (mg/dL) 12.52 ± 1.15 12.29 ± 1.34 0.22 ± 1.1 0.17
Hematocrit
Male 34.8–43.9 (%) 43.3 ± 2.93 44.79 ± 2.42 1.3 ± 2.8 0.01
Female 34–40.7 (%) 38.73 ± 2.89 38.01 ± 3.68 − 0.74 ± 3.74 0.21
MCV 83–101 (f/L) 81.16 ± 6.03 83.45 ± 6.68 2.29 ± 4.12 < 0.0001
Iron 5.4–28.6 (μmol/L) 10.31 ± 4.87 15.11 ± 7.87 4.80 ± 4.89 < 0.0001
Ferritin 11–304 (mcg/L) 29.50 ± 25.19 34.72 ± 37.79 5.22 ± 25.62 0.64
Total protein 64–83 (g/L) 73 ± 4.16 69.88 ± 4.63 − 3.13 ± 5.36 < 0.0001
Albumin 40–150 (mg/L) 41.14 ± 4.06 40.38 ± 4.67 − 0.77 ± 4.16 0.13
Calcium 2.1–2.5 (mmol/L) 2.28 ± 0.12 2.55 ± 1.79 0.28 ± 1.81 0.32
Magnesium 0.72–1.04 (mmol/L) 0.81 ± 0.04 0.81 ± 0.04 0.00 ± 0.06 0.91
Phosphate 0.89–1.66 (mmol/L) 1.55 ± 0.22 1.50 ± 0.19 − 0.05 ± 0.15 0.40
Zinc 10.1–16.8 (μmol/L) 12.75 ± 1.25 11.98 ± 1.22 − 0.77 ± 1.84 0.28
Copper 11–22 (μmol/L) 21.32 ± 2.26 16.87 ± 3.45 − 4.45 ± 3.91 0.04
Vitamin D 30–50 (ng/mL) 11.73 ± 6.06 17.73 ± 9.33 6.00 ± 11.11 < 0.0001
Vitamin B12 133–675 (pmol/L) 256.51 ± 106.71 271.22 ± 227.64 − 14.71 ± 229.17 0.036
Folic acid 4–45 (nmol/L) 20.41 ± 11.30 14.40 ± 10.74 − 6.01 ± 12.42 0.07
M mean, SD standard deviation, Difference postoperative value minus preoperative value, MCV mean cell volume
aMean follow-up = 24.2 ± 12.28 months
Table 1 Mean preoperative and postoperative anthropometric values of
the study sample
Parameter Preop
M (SD)
Postopa
M (SD)
P Difference
M (SD)
Weight 126.15 (22.76) 78.5 (13.17) < 0.0001 51.82 (28.05)
BMI (kg/m2) 46.04 (5.99) 28.30 (6.07) < 0.0001 17 (6.24)
EW (kg) 66 (19.54) 21 (14.9) < 0.0001 47.94 (19.84)
EWL (%) – 81.08 (19.65) – –
M mean, SD standard deviation, Difference preop value minus postop
value, BMI body mass index, EW excess weight, EWL (%) excess weight
loss (%),— not applicable
aMeasured at a mean of 24.2 months
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adults, moreweight reduction is usually achieved in patients with
higher preoperative BMI [25]. Such controversy suggests that the
relationship between the initial BMI and the magnitude of post-
operative weight reduction might not be entirely linear, with
other intervening factors potentially influencing/moderating this
relationship. Future research should explore these relationships.
Likewise, mean decline in BMI and EWL% in our study agreed
with or exceeded the values reported elsewhere [9, 26]. The
finding that most adolescents in our study achieved and main-
tained a meaningful weight loss for at least 2 years postopera-
tively suggests that compared to adults, adolescents treated with
bariatric surgery may have a better potential for the reversal of
anthropometric parameters [9].
Nutritional Outcomes
Generally, we observed no preoperative or postoperative defi-
ciencies of trace elements/minerals, except for one de novo case
of copper deficiency. Adequate levels of trace elements/minerals
are important, given their critical roles in the immune system,
cell/neuromuscular functions, wound healing, and bone health.
We found no comparable published studies on post-bariatric sur-
gery trace element/mineral changes among adolescents.
Nevertheless, among adult populations, others have reported
post-bariatric surgery deficiencies in zinc of 7–15% and 0–5%
in copper [27].
Vitamin D was the most prevalent deficiency in our study
(96.4% preoperatively), and exceeded deficiencies reported
by others [28, 29]. Moreover, this deficiency persisted 2 years
later (89.3% postoperatively) and remained higher than other
reports [9]. Such vitamin D deficiency may be driven by un-
derexposure to ultraviolet radiation, malabsorption, and de-
creased bioavailability due to enhanced uptake by adipose
tissue [30]. Despite of persistent vitamin D deficiency preop-
eratively and postoperatively, the incidence of hypocalcemia
remained low (4.7%). On the other hand, hyperparathyroidism
related to vitamin D deficiency was present among only 33.3
and 16.7% of adolescents preoperatively and postoperatively,
lower than levels in other studies [6, 31], probably due to the
high prevalence of vitamin D among our sample. The persis-
tence of postoperative vitamin D deficiency and secondary
hyperparathyroidism highlights the need to assess the optimal
vitamin D and calcium supplementation doses necessary to
preserve bone health.
With regards to hemoglobin, about one third of our adoles-
cents had low preoperative hemoglobin levels, confirming the
high risk of anemia among young populations [32].
Postoperatively, the percentage of patients with low hemoglobin
levels significantly decreased among males (from 39.4 to
15.2%), but only modestly reduced among females (from 31.7
to 29.3%), probably due to menstrual loss, suggesting the need
for additional iron supplementation among young females.
However, our percentage of patients with iron deficiency was
twice than that reported among adolescents who underwent gas-
tric banding [33], probably due to the decreased hydrochloric
acid production essential for iron absorption after gastric resec-
tion, along with the reduced intake of iron-rich food such as red
meat [34].
In terms of albumin levels, the 29.6% rate of albumin defi-
ciency was high compared with other studies (3%) [9]. The per-
centage of our patients with hypoalbuminemia increased to
38.3% postoperatively (14 de novo cases), in contrast to other
research that reported no albumin deficiency post-LSG [9]. This
albumin deficiency can be explained by LSG’s restrictive nature,
and the observed intolerance to protein-rich food postoperatively
[35]. High post-LSG protein intake is hence encouraged for ad-
olescents especially with the rapid weight loss during the first
Table 3 Evolution of nutritional deficiencies among the study sample
Parameter Preop
N (%)
Postopa
N (%)
Pb De novo
N (%)
Hemoglobin
Male 13 (39.4) 5 (15.2) 0.02 1 (3.0)
Female 13 (31.7) 12 (29.3) 0.99 4 (9.8)
Hematocrit
Male 0 (0) 2 (5.9) NA 5 (5.9)
Female 2 (4.9) 4 (9.8) 0.69 4 (9.8)
MCV (micro def.)d
Male 7 (20.6) 2 (5.9) 0.06 0 (0)
Female 11 (27.5) 8 (20) 0.45 2 (5)
Iron 5 (20.8) 4 (16.7) 0.99 1 (4.2)
Ferritin 2 (33.3) 2 (33.3) 0.99 1 (16.7)
Total protein 0 (0) 3 (4.6) NA 3 (4.6)
Albumin 21 (29.6) 27 (38) 0.29 14 (19.7)
Calcium 2 (4.7) 2 (4.7) 0.99 1 (2.3)
Magnesium 0 (0) 0 (0) NA 0 (0)
Phosphate 0 (0) 0 (0) NA 0 (0)
Zinc 0 (0) 0 (0) NA 0 (0)
Copper 0 (0) 1 (16.7) NA 1 (16.7)
Vitamin D 54 (96.4) 50 (89.3) 0.29 2 (3.6)
Vitamin B12 3 (6.7) 6 (15.3) 0.38 4 (8.9)
Folic acid 0 (0) 0 (0) NA 0 (0)
N number, NA not applicable, MCV mean cell volume
aMean follow-up = 24.2 ± 12.28 months
bMcNemar chi-squared test
c Percentage of participants with deficiency calculated as the number of
participants (among those for whom sufficient data were available both
preoperatively and postoperatively to determine whether the coexisting
condition was present), divided by the number of participants (among
those for whom sufficient data were available preoperatively and
postoperatively)
d Representingmicrocytic deficiency (MCV< 83) in anemic patients only
(i.e., patient with deficient hemoglobin levels)
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year. Protein shake supplements can be provided as and alterna-
tive in case of protein intolerance.
Cardiometabolic Outcomes
Generally, the percentage of patients with cardiometabolic ab-
normalities significantly decreased postoperatively. Post-LSG
lipid profile among adolescents is critical, as there is correlation
between adolescent combined dyslipidemia (elevated LDL and
TG, low HDL) and atherosclerosis, with subsequent premature
coronary artery disease [36]. Hence, understanding the lipid dy-
namics among post-LSG adolescents is critical. In our study, the
majority of adolescents exhibited elevated LDL levels preoper-
atively, higher than others [37]. However, our LDL levels sig-
nificantly decreased postoperatively, matching findings ob-
served in Saudi Arabia [17]. Likewise, we detected 83.3%
hypertriglyceridemia remission rate, confirming previous find-
ings [14, 17]. Such improvements in hypertriglyceridemia after
bariatric surgery can be due to reduced abdominal fat and de-
creased flux of free fatty acids to the liver, resulting in decreased
hepatic secretion of triglyceride-rich lipoproteins [38].
In addition, the percentage of our patients with low HDL
exceeded that reported for obese adolescents in the USA [37].
Despite such elevated preoperative levels, we observed a sig-
nificant drop in the low HDL levels postoperatively with
(100%) remission rate, higher than reported in by others [15,
17]. Such increase of HDL is attributed to increased physical
activity and was found protective against atherosclerosis
mainly through suppressing LDL accumulation, inflamma-
tion, and thrombosis [39]. Finally, the incidence of our elevat-
ed TC preoperatively is within the range reported by others
[17, 40], and while it significantly decreased postoperatively,
our remission rate (29.5%) was lower than in other studies
(58.3%) [41]. Overall, our observed improvements in lipid
profile support the proposal that adolescents may have better
potential than adults for the reversal of dyslipidemia [9].
However, randomized controlled trials are needed to demon-
strate LSG’s long-term effects on reduction of atherogenic
lipids and subsequent cardiovascular disease prevention in
adulthood.
Table 4 Preoperative and postoperative mean values of cardiometabolic parameters
Parameter Normal value (unit) Preop
M ± SD
Postopa
M ± SD
Difference
M ± SD
P
TC < 5.17 (mmol/L) 4.57 ± 0.74 4.28 ± 0.61 0.29 ± 0.78 0.02
LDL < 3.36 (mmol/L) 2.92 ± 0.78 2.67 ± 0.66 0.26 ± 0.73 0.04
HDL > 1 (mmol/L) 1.14 ± 0.26 1.29 ± 0.33 − 0.14 ± 0.27 0.003
TG < 1.7 (mmol/L) 1.13 ± 0.47 0.83 ± 0.41 0.30 ± 0.50 0.001
ALT 9–24 (U/L) 31.03 ± 19.54 17.68 ± 15.67 13.35 ± 19.40 < 0.0001
AST 13–26 (U/L) 23.12 ± 9.79 18.14 ± 8.85 4.98 ± 11.85 0.002
FBG 3.5–5.5 (mmol/L) 5.71 ± 3.14 4.85 ± 2.05 0.86 ± 2.18 0.006
HbA1c 4.8–6 (%) 6.55 ± 2.61 5.48 ± 1.44 1.07 ± 1.59 0.001
PTH 15–65 (pg/mL) 56.58 ± 23.23 52.83 ± 40.54 3.75 ± 42.30 0.77
Uric Acid 150–350 (mmol/L) 355 ± 67.97 356 ± 85.52 − 1.11 ± 38.58 0.93
Mmean, SD standard deviation,Difference postoperative value minus preoperative value, TC total cholesterol, LDL low-density lipoprotein,HDL high-
density lipoprotein, TG total triglycerides, ALT alanine amino transferase, AST aspartate aminotransferase, FBG fasting blood glucose, HbA1c glyco-
sylated hemoglobin
aMean follow-up = 24.2 ± 12.28 months
Table 5 Evolution of cardiometabolic parameters of the sample
Parameter Preop Postopa Pb Remission De novo
N (%) N (%) N (%) N (%)
TC 10 (20.8) 3 (6.3) 0.06 13 (29.5) 4 (9.1)
LDL 11 (66.1) 7 (38.9) < 0.0001 8 (21.1) 2 (5.37)
HDL 12 (32.4) 7 (18.9 0.27 37 (100) 0 (0)
TG 4 (10.3) 1 (2.6) 0.38 35 (83.3) 0 (0)
ALT 29 (45.3) 7 (10.9) < 0.0001 22 (75.9) 0 (0)
AST 14 (24.1) 5 (8.6) 0.03 12 (85.7) 3 (5.2)
Prediabetes 17 (12.6) 4 (5.0) < 0.0001 17 (100.0) 0 (0)
T2DM 10 (12.6) 6 (7.6) < 0.0001 8 (80.0) 0 (0)
Uric acid 6 (66.7) 3 (33.3) 0.25 3 (50.0) 0 (0)
PTH 4 (33.3) 2 (16.7) 0.63 3 (75.0) 1 (8.3)
TC total cholesterol, NA not applicable, LDL low-density lipoprotein,
HDL high-density lipoprotein, ALT alanine aminotransferase, AST aspar-
tate aminotransferase, T2DM type 2 diabetes
aMean follow-up = 24.2 ± 12.28 months
bMcNemar chi-squared test
c Percentage of participants with metabolic abnormality calculated as the
number of participants (among those for whom sufficient data were avail-
able both preoperatively and postoperatively to determine whether the
coexisting condition was present), divided by the number of participants
(among those for whom sufficient data were available preoperatively and
postoperatively)
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In terms of uric acid, in Japan, 20.7% of obese adolescents
had hyperuricemia [42], probably linked to metabolic syndrome
and insulin resistance [43, 44]. Our incidence of preoperative
hyperuricemia decreased from 66.7 to 33.3% postoperatively,
possibly due to enhanced insulin sensitivity after LSG [45].
Among obese adolescents, an increased incidence of non-
alcoholic fatty liver disease (NAFLD) was reported. Elevated
aminotransferases act as surrogate NAFLD markers which
predict subsequent diabetes, metabolic syndrome, and cirrho-
sis [46, 47]. Others have reported elevated ALT among obese
boys and girls [48]. Our prevalence of elevated ALT levels
significantly decreased postoperatively with 75.9% remission
rate. Likewise, obese adolescents also have higher prevalence
of elevated ASTcompared to normal weight adolescents (14.9
vs. 6.6%) [49]. Our preoperative AST prevalence, although
higher than others [50], significantly decreased postoperative-
ly. We agree with others where liver enzymes improved 1 year
after surgery amounting to 55.6% (post-gastric bypass) and
33.3% (post-gastric band) [51], and with a study in Sweden
that reported marked AST and ALT improvements post-
gastric bypass [24]. Factors that improve liver enzymes in-
clude the beneficial effects of weight loss, better insulin sen-
sitivity, improved dyslipidemia, and reduced inflammatory
markers [52]. Hence, early bariatric surgery should be consid-
ered for adolescents with NAFLD. Future research should
further examine such effects.
Although the 12.6% prevalence of prediabetes in our study
was higher than that reported by others [2, 53], we observed
100% remission prediabetes rate which is identical to findings
in other studies [9, 17]. However, our preoperative T2DM
prevalence was lower than that in Saudi Arabia (23%) [17]
and USA (14%) [2]. Although T2DM traditionally affects
adults, its incidence has dramatically increased among adoles-
cents [54], probably linked to sedentary lifestyle, obesity, and
insulin resistance [55]. Our prevalence of T2DM significantly
decreased post-LSG (80% remission rate), comparable to oth-
er remissions reported after LSG (88.5–100%) [9, 17], gastric
banding (59.1%), and gastric bypass (78.6%) [52].
Prediabetes and T2DM remission and concomitant HbA1c
improvements are related to better insulin sensitivity and glu-
cose metabolism that influence weight-dependent (body
weight loss) and independent (hormonal glucagon-like pep-
tide 1) pathways. This hormone stimulates glucose-dependent
insulin secretion fromβ cells, inhibits glucagon secretion, and
may increase peripheral glucose uptake and insulin sensitivity
[56]. Given the potential complications of adolescent T2DM,
improvements of T2DM post-bariatric surgery provide further
evidence for its validity as an effective treatment option of
adolescent T2DM [57].
This study has limitations. It would have been beneficial to
have patient data on preoperative and postoperative food con-
sumption, diet regimens, and intake of vitamins/other supple-
ments that could have influenced the observed nutritional and
cardiometabolic changes. In addition, we provide our post-
LSG patients with specific dietary/supplementation protocols,
but compliance is difficult to assess. Longer (5 years) post-
LSG follow-up of our adolescents’ nutritional profiles would
have been useful to assess other longer term effects. Finally,
we had a 77.5% follow-up rate, slightly lower than the ideal
follow-up of ≥ 80%, which is rarely accomplished even in the
most cited bariatric surgery outcome research [58–60].
Nevertheless, the study has several strengths. We examined
a wide variety of parameters (25 anthropometric, nutritional,
and cardiometabolic). To date, no study has examined, in sim-
ilar detail, such as broad range of parameters after LSG among
adolescents. We focused on only one bariatric procedure
(LSG) rather than a range of bariatric techniques (gastric band,
gastric bypass); hence, our findings are specific to post-LSG
consequences, “unaffected” by results of other bariatric pro-
cedures that could have potentially influenced the nutritional/
cardiometabolic outcomes after surgery. With a few excep-
tions, very few studies have achieved such results [9, 17].
Conclusion
Our findings confirm that, among obese adolescents, LSG
achieves significant weight loss and improves anthropometric
parameters and 10 cardiometabolic risk factors, without the
development of trace element deficiency after surgery.
Conversely, the preoperative nutritional deficiencies (vitamin
D, anemia, and hypoalbuminemia) persisted or worsened
postoperatively. Such nutritional deficiencies warrant careful
and specific preoperative surveillance and appropriate postop-
erative monitoring and nutritional supplementation, especially
during the adolescence period, in order to ensure healthy de-
velopment and growth. Longer follow-up of adolescents’ nu-
tritional profiles is recommended to assess other potential ef-
fects of LSG.
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